Mabion SA

About Mabion SA

Mabion is a fully integrated CDMO providing comprehensive GMP development and manufacturing services for biotherapeutics, including monoclonal antibodies, vaccine antigens, and recombinant proteins. We offer end-to-end solutions - from cell line development and process scale-up to analytics, fill & finish, and quality control. Specialized in bispecific antibodies, ADCs, a...

Certifications
  • Country/Region:
    Poland
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
CMO/CDMO
Primary activities
Analytical Services
Biopharmaceutical
Clinical Research
Contract Manufacturer
Contract Research Organisation
End-product distributor (Wholesale)
Intermediates Manufacturer
Contact info

Products from Mabion SA (3)

  • MabionCD20

    Product MabionCD20

    This is our most advanced in-house project. A MabThera/Rituxan (rituximab) biosimilar drug, whose efficacy and safety were clinically confirmed. It is the first such advanced drug developed in Poland. We are currently at the final stage of works aimed at marketing the drug in Europe and the United States.
  • Analytical Services

    Product Analytical Services

    Mabion offers a extensive suite of Analytical Services to ensure safety, efficacy and quality of your biologic product. Our portfolio includes development, optimization and validation of analytical methods, as well as stability studies, GMP release testing and in-depth drug characterization. In addition to...
  • Drug Substance Manufacturing services

    Product Drug Substance Manufacturing services

    Mabion offers advanced Drug Substance Manufacturing services encompassing various types of biologics, antibodies (including multi-specifics and ADC), fusion proteins, enzymes and vaccine antigens. Our state-of-the-art facilities offer 25L – 8000L scale GMP DS batch size for mammalian and insect cell line p...

Mabion SA Resources (2)